Annamaria Vincenzi

7PUBLICATIONS
11CO-AUTHORS
Liquid biopsiesHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 03, 2025
The progression at 24 months (POD24) induces a high risk of transformation of follicular lymphoma: A systematic biopsy verification.

Marco Picardi, Annamaria Vincenzi, Novella Pugliese

|Nov 17, 2025
Thrombotic complications of central venous catheterization with peripherally inserted catheters in patients with classical-Hodgkin lymphoma.

Marco Picardi, Claudia Giordano, Annamaria Vincenzi

|Nov 06, 2025
Brentuximab Vedotin With Adriamycin, Vinblastine, and Dacarbazine for Patients Aged 18-59 Years With Untreated Advanced Stage Classical Hodgkin Lymphoma: The Largest Real-Life Series From Southern Italy Cancer Centers.

Marco Picardi, Annamaria Vincenzi, Claudia Giordano

|Oct 20, 2025
Liposomal doxorubicin in place of doxorubicin hydrochloride to prevent anthracycline-induced cardiomyopathy in elderly patients with Hodgkin lymphoma.

Marco Picardi, Annamaria Vincenzi, Novella Pugliese

|Oct 16, 2025
Routine Imaging Surveillance After Frontline ABVD Improves Outcome in High-Risk Hodgkin Lymphoma.

Novella Pugliese, Marco Picardi, Annamaria Vincenzi

|Apr 03, 2025
Bendamustine supercharge plus brentuximab vedotin as early salvage therapy following failure to obtain complete metabolic remission after two cycles of adriamycin-bleomycin-vinblastine-dacarbazine for classic Hodgkin lymphoma in patients aged ≤ 60 years: Long-term efficacy results of a retrospective multicentre study.

C Giordano, M Picardi, N Pugliese

Pageof 2

Frequent Collaborators

6 joint publications

Novella Pugliese

5 joint publications

Claudia Giordano

3 joint publications

Massimo Mascolo

2 joint publications

Marco Picardi